AARTI DRUGS
Quarterly Results Analysis [Dec2023]
AARTI DRUGS Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹606 Cr | ₹642 Cr | ₹661 Cr | ₹742 Cr | ₹664 Cr | ₹688 Cr | ₹622 Cr | ₹694 Cr |
Expenses | ₹536 Cr | ₹565 Cr | ₹577 Cr | ₹649 Cr | ₹593 Cr | ₹613 Cr | ₹555 Cr | ₹608 Cr |
Operating Income | ₹70 Cr | ₹76 Cr | ₹84 Cr | ₹94 Cr | ₹71 Cr | ₹74 Cr | ₹67 Cr | ₹86 Cr |
Other Income | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹3 Cr |
Interest | ₹8 Cr | ₹8 Cr | ₹9 Cr | ₹9 Cr | ₹9 Cr | ₹8 Cr | ₹7 Cr | ₹6 Cr |
Depreciation | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr | ₹13 Cr |
Profit Before Tax | ₹52 Cr | ₹56 Cr | ₹64 Cr | ₹73 Cr | ₹50 Cr | ₹53 Cr | ₹48 Cr | ₹71 Cr |
Profit After Tax | ₹37 Cr | ₹40 Cr | ₹48 Cr | ₹56 Cr | ₹37 Cr | ₹39 Cr | ₹35 Cr | ₹55 Cr |
EPS | ₹3.99 | ₹4.31 | ₹5.17 | ₹6.06 | ₹3.96 | ₹4.18 | ₹3.76 | ₹5.98 |
Industry Peers & Returns | 1W | 1M | 1Y |
AARTI DRUGS | -0.8% | -16.4% | 18.3% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
AARTI DRUGS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -5.55 % |
Y-o-Y | -8.74 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹606 Cr | -5.55 | |
Sep2023 | ₹642 Cr | -2.96 | |
Jun2023 | ₹661 Cr | -10.95 | |
Mar2023 | ₹742 Cr | 11.82 | |
Dec2022 | ₹664 Cr | -3.45 | |
Sep2022 | ₹688 Cr | 10.57 | |
Jun2022 | ₹622 Cr | -10.42 | |
Mar2022 | ₹694 Cr | - |
AARTI DRUGS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -8.25 % |
Y-o-Y | -0.72 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹70 Cr | -8.25 | |
Sep2023 | ₹76 Cr | -9.06 | |
Jun2023 | ₹84 Cr | -10.12 | |
Mar2023 | ₹94 Cr | 32.40 | |
Dec2022 | ₹71 Cr | -4.87 | |
Sep2022 | ₹74 Cr | 10.62 | |
Jun2022 | ₹67 Cr | -21.93 | |
Mar2022 | ₹86 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -2.85 % |
Y-o-Y | 8.83 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 11.58% | -2.85 | |
Sep2023 | 11.92% | -6.29 | |
Jun2023 | 12.72% | 0.95 | |
Mar2023 | 12.6% | 18.42 | |
Dec2022 | 10.64% | -1.48 | |
Sep2022 | 10.8% | 0.09 | |
Jun2022 | 10.79% | -12.91 | |
Mar2022 | 12.39% | - |
AARTI DRUGS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -7.30 % |
Y-o-Y | 0.11 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹37 Cr | -7.30 | |
Sep2023 | ₹40 Cr | -17.45 | |
Jun2023 | ₹48 Cr | -14.61 | |
Mar2023 | ₹56 Cr | 53.20 | |
Dec2022 | ₹37 Cr | -5.34 | |
Sep2022 | ₹39 Cr | 11.39 | |
Jun2022 | ₹35 Cr | -37.13 | |
Mar2022 | ₹55 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -1.78 % |
Y-o-Y | 9.78 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 6.06 % | -1.78 | |
Sep2023 | 6.17 % | -15.01 | |
Jun2023 | 7.26 % | -4.10 | |
Mar2023 | 7.57 % | 37.14 | |
Dec2022 | 5.52 % | -1.95 | |
Sep2022 | 5.63 % | 0.72 | |
Jun2022 | 5.59 % | -29.86 | |
Mar2022 | 7.97 % | - |
AARTI DRUGS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -7.42 % |
Y-o-Y | 0.76 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹3.99 | -7.42 | |
Sep2023 | ₹4.31 | -16.63 | |
Jun2023 | ₹5.17 | -14.69 | |
Mar2023 | ₹6.06 | 53.03 | |
Dec2022 | ₹3.96 | -5.26 | |
Sep2022 | ₹4.18 | 11.17 | |
Jun2022 | ₹3.76 | -37.12 | |
Mar2022 | ₹5.98 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD